Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fatty acid-binding proteins (FABPs) form a conserved family of small (∼14-15 kDa) intracellular proteins, each with tissue-specific expression that reflects their specialized roles in lipid handling. FABPs bind long-chain fatty acids and related hydrophobic molecules with high affinity, facilitating their solubilization and transport to various compartments (nucleus, mitochondria, endoplasmic reticulum). They enable efficient intracellular trafficking of fatty acids for metabolism, storage, and signaling. Individual FABP subtypes are highly conserved across species and are central to systemic lipid metabolism, gene expression regulation, immune response, and cellular stress adaptation. FABPs have gained substantial interest as both diagnostic biomarkers (indicative of tissue injury or disease) and therapeutic targets for disorders ranging from diabetes and cardiovascular disease to some cancers and inflammatory conditions.
Inhibition of fatty acid binding/transport Modulation of lipid signaling pathways Regulation of gene expression through altered lipid trafficking Some drugs act as competitive inhibitors of the FABP binding site
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fatty acid-binding proteins (FABP).